Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 07 - 23 entities : Abbvie inc. save search
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-07-23 (Crawled : 00:00) - fda.gov
XERS | $1.77 -0.56% -0.56% 1.1M
|
Health Technology
| Email alert
Add to watchlist
BCRX | $4.49 -1.97% -2.0% 3M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
| Email alert
Add to watchlist
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
| Email alert
Add to watchlist
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
| Email alert
Add to watchlist
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
| Email alert
Add to watchlist
OMER | $3.22 -3.59% -3.73% 430K
|
Health Technology
| Email alert
Add to watchlist
SCYX | $1.47 3.52% 3.4% 80K
|
Health Technology
| Email alert
Add to watchlist
OTIC | $0.077
|
Health Technology
| Email alert
Add to watchlist
DALVANCE® (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients
Published: 2021-07-23 (Crawled : 17:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
fda fda approval skin approval injection infections
Global Antibody Market Expected to Reach USD 318,482.1 Million by 2027, With a CAGR Of 10.1% | Growth Market Reports
Published: 2021-07-23 (Crawled : 14:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.06%
H: 0.78%
C: 0.5%
BIO | News | $281.02 -3.38% -0.36% 370K
|
Health Technology
|
| O: 0.22%
H: 1.29%
C: 0.89%
BDX | $233.15 0.41% 0.15% 890K
|
Health Technology
|
| O: 0.26%
H: 0.63%
C: 0.43%
A | $132.44 -1.57% -0.36% 1.9M
|
Health Technology
|
| O: 0.31%
H: 0.0%
C: 0.0%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
antibody growth
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.